WILLIAM J. LINK PHD - 16 Sep 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
16 Sep 2025
Net transactions value
$0
Form type
4
Filing time
18 Sep 2025, 17:00:33 UTC
Previous filing
10 Sep 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LINK WILLIAM J PHD Director C/O TARSUS PHARMACEUTICALS, INC., 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE /s/ Scott Sieckert, Attorney-in-Fact 18 Sep 2025 0001228684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Gift $0 -2,000 -1.4% $0.000000 141,332 16 Sep 2025 Direct
holding TARS Common Stock 10,446 16 Sep 2025 By Link Family Enterprise, LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.